Andy Hsieh

Stock Analyst at William Blair

(0.63)
# 3,165
Out of 4,667 analysts
4
Total ratings
50%
Success rate
-18.36%
Average return

Stocks Rated by Andy Hsieh

Lantheus Holdings
Sep 29, 2023
Initiates: Outperform
Price Target: n/a
Current: $87.32
Upside: -
FibroGen
Jun 26, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $0.39
Upside: -
Actinium Pharmaceuticals
Feb 21, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.47
Upside: -